Nazli Okumus
@nazliokumus
Followers
1,033
Following
1,323
Media
143
Statuses
1,138
IC fellow @AHNtoday | @CardioNerds IC Committee Chair | Editorial fellow @ACCinTouch | @SCAI PAC | #NCDRCathPCI | @SCAI_WIN | tweets my own
Pittsburgh, PA
Joined May 2019
Don't wanna be here?
Send us removal request.
Explore trending content on Musk Viewer
Liam Payne
• 2140858 Tweets
Hobi
• 843316 Tweets
ブロック
• 353054 Tweets
Twitterくん
• 274290 Tweets
西田さん
• 177734 Tweets
西田敏行さん
• 163060 Tweets
俳優さん
• 133294 Tweets
#AgathaAllAlong
• 113001 Tweets
ツイッター
• 100544 Tweets
東京の自宅
• 81006 Tweets
Bluesky
• 79812 Tweets
ミュート
• 62303 Tweets
規約変更
• 56206 Tweets
イーロン
• 47277 Tweets
pixiv
• 44595 Tweets
महर्षि वाल्मीकि
• 44128 Tweets
AI学習
• 41377 Tweets
ブルスカ
• 40519 Tweets
ぐりとぐら
• 35342 Tweets
中川李枝子さん
• 30009 Tweets
#ArrestMaulanaRashidi
• 28387 Tweets
#INDvNZ
• 21896 Tweets
블루스카이
• 21891 Tweets
他のSNS
• 18428 Tweets
池中玄太80キロ
• 15861 Tweets
タイッツー
• 15765 Tweets
PLUTO PRESS TOUR
• 14335 Tweets
世田谷区
• 13853 Tweets
ドクターX
• 13654 Tweets
そらいろのたね
• 12780 Tweets
Misskey
• 11429 Tweets
Thrilled to announce that I’ve been selected to serve on
@SCAI
Women in Innovations Committee! Looking forward to contributing to the efforts to empower women in
#interventionalcardiology
!
@SCAI_WIN
@AHN_CVI
9
3
84
One test doesn't fit all in ICU care. Great review to better understand management of MCS in cardiogenic shock
#CardioTwitter
#ACCFIT
#MedTwitter
From
@jaccjournals
0
17
53
Exciting news! The
#MINT
trial is here, addressing anemia in acute MI patients.
@cardioNerds
Should we opt for restrictive or liberal transfusion strategies?
#AHA23
Comparing risk of death/MI at 30 days in acute MI patients. Restrictive (Hb 7-8) vs. liberal (Hb 10) transfusion.
1
20
45
IC Fellowship Match Task Force
#SCAI2022
More to come!
@SCAI
@AdnanKhalifMD
@david_enze_wang
@CardioNerds
@Dr_DanMD
@AmitGoyalMD
0
5
43
Thrilled to continue my journey with
@ACCinTouch
as part of the NCDR CathPCI Registry R&P Subcommittee! Huge thanks to
@AdnanKhalifMD
for being an incredible mentor. Lucky to have your support. Grateful to
@victorfarah75
@KhandelwalMD
@rosspetersonmd
for their encouragement!
7
3
43
Our review on TAVR in HF patients. Humbled to be part of such a great team! Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the ...
@manreetkanwar
@SonuAbrahamMD
@BiykemB
@AHN_CVI
@AdnanKhalifMD
@WilsonTangMD
@JACCJournals
@ACCinTouch
1
12
38
Transformation in Acute MI Care: Door to Balloon or Door to Unload?
#STEMI
#DTU
#RCT
is currently enrolling.
We discussed what we have learned about LV unloading prior to revascularization in acute MI at
#THT2023
via
@mydocwire
1
9
37
Support
@MyJSCAI
at
#SCAI2022
! This peer-reviewed Open Access journal is am excellent resource for interventional cardiologists.
@SCAI
@CardioNerds
@PoojaMishraMD
1
4
35
Excited to share my interview from
#AHA2023
diving deep into the MINT trial on transfusion strategies post-AMI with Dr Jeffrey Carson.
The results open intriguing possibilities for redefining transfusion thresholds in MI. Don’t miss the compelling discussion here
@CardioNerds
🎙️NEW
#AHA23
Discussion in partnership with
@CardioNerds
💫Dr Jeffrey Carson and CardioNerds Ambassador Dr
@nazliokumus
discuss findings from the MINT trial comparing liberal and restrictive red blood cell transfusion strategies in anaemic patients with AMI.
📽️Watch here👉
0
3
1
1
16
33
Excellent talk from
@NavinKapur4
about new approaches to limit complications on VA-ECMO
#THT2023
❣️ Hyperoxemia on VA-ECMO is associated with lower survival
❣️Timing of Impella insertion for LV unloading is critical
🌟Impella before ECMO limits myocardial damage
1
11
33
Excited to share findings from the
#DanGer
trial
#ACC24
from Jacob Moller
@CardioNerds
#cardiogenicshock
#ImpellaCS
🫀international, multicenter, randomized trial
🫀patients with STEMI and cardiogenic shock were assigned to Impella CP vs standard care only
#NEJM
1
10
33
Thrilled to be a
@Cardionerds
Scholar for
#ACC23
/
#WCCardio
! Follow us during the conference for live updates.
@ACCinTouch
#ACCFIT
#ACCWIC
@PaChapterACC
@AHN_CVI
#CardioTwitter
#MedTwitter
1
6
32
Super thrilled to be part of the amazing
@CardioNerds
team at
#AHA23
! The countdown begins for an incredible experience🫀
@NaimaMaqsood9
@SukritiBanthiya
@MaryamBMD
@HanadBashirMD
@RamyDossMD
@A_h_Ghoneem
@HanchateShivani
@Kamal_mz
@CATweneboah
@InchausteguiC
@AHN_CVI
🚨👀 Looking for a way to stay up on the breaking news and info from
#AHA23
?!
Look no further! 😎
Follow the
@CardioNerds
Conference Scholars 🤓⬇️ for live updates and 🔥 important points during the AHA 🫀 Scientific Session this weekend.
3
27
75
0
4
29
🫀When managing Valvular shock, a comprehensive understanding of hemodynamics and nuances in temporary MCS devices is crucial.
🫀
@PedroMDMSc
delves into this complex subject, providing examples from challenging cases at
@miamivalves
@CardioNerds
2
9
27
My article in collaboration with
@CardioNerds
and
@DocWire
. Discover how
#ORBITA2
trial revolutionizes patient-centered care in stable angina and shapes future trial designs
@rajkumar_chris
@rallamee
#AHA23
1
14
27
Excellent presentation from
@AdnanKhalifMD
at the last session of
#FellowsSummit
#SCAI2022
Generated amazing discussions and teaching points as always! We are extremely lucky to have such a great IC fellow, teacher and mentor
@AHN_CVI
@CardioNerds
@SCAI
1
3
27
Lifetime management of AS: coronary artery protection im TAVR in valve or TAVR in TAVR
@miamivalves
@CardioNerds
🫀ShortCut has been used in multiple bioprosthetic valves invluding TAVR valves
1
5
27
In Turkey, a young cardiologist was murdered today while on duty! We are so sad, we are so grieved. We will never forget this day
#EkremKarakaya
1
5
24
Nightmares at CICU: HOCM with cardiogenic shock
#critcarecards23
@nyulangone
❣️It’s crucial to recognize patients with Takotsubo Syndrome at risk for SAM
❣️ Review prior echo to look for those at risk for LVOT obstruction
❣️ If doing a LHC, obtain the post-PVC LVOT gradients
1
12
26
We are ready for the Congressional Office visits
#ACCLegConf
to discuss;
❣️Improving heart health for all
❣️Increasing patient access to care
❣️Protecting clinican well-being
@Cardiology
@ACCinTouch
@PaChapterACC
#ACCWIC
#ACCFIT
@AHN_CVI
1
4
26
Amazing presentation about early PA Catheter use from our Interventional & Critical Care Cardiology fellow and future faculty
@AdnanKhalifMD
@AHN_CVI
#ACC23
#WCCardio
@manreetkanwar
@MahabirSunita
@MNestasie
#MedTwitter
#CardioTwitter
#ACCFIT
@ACCinTouch
0
7
26
1
5
24
2
5
23
TRILUMINATE Pivotal trial 12 month results were presented
@ACCinTouch
#ACC2023
. Thank you for the opportunity to write this piece
@mydocwire
@CardioNerds
@Dr_DanMD
@AmitGoyalMD
@AHN_CVI
via
@mydocwire
0
5
25
Giving their awards to the Poster Session Winners of the SIM section
@kathrynchadason
and
@jducanto
#CRITCARECARDS23
“Modified Cadaver Technique to Simulate Contaminated Airway Scenarios to Train Medical Providers in Suction Assisted Laryngoscopy Airway Decontamination
2
7
23
It’s a wrap!
#CRITCARECARDS23
@nyulangone
was the place to be this weekend to learn from the experts in the field, run into friends/colleagues and meet many more amazing people
@CardioNerds
@BalimSenmanMD
@david_enze_wang
@Gurleen_Kaur96
@catweneboah
@AnnGageMD
@melsulistio
0
8
23
MCS in PAH/RV shock
#THT2023
🫀Once PAH patient is in ICU with RV shock, mortality is high
🫀Very narrow window to transition to MCS
🫀we still have a lot more to learn about the optimal MCS strategy in this patient population
@CardioNerds
@sonuabrahammd
0
10
22
#THT2023
Executing the optimal Cardiogenic Shock trial
🫀Details matter
🫀Need for RCT’s in more specific populations
🫀Patient selection is critical and using SCAI stages can be the key
🫀What happens within the first 24 hours predicts outcomes
1
8
21
Taking a break from a plethora of exciting LBCTs to present our trial findings at
#AHA23
with the amazong mentorship of
@skarim01
Stay tuned for insights!
@CardioNerds
@AHN_CVI
@GSAMRA12
@metrohealthCLE
#ACCWIC
2
6
22
@CardioNerds
at the 3rd NYU Langone Critical Care Symposium
#critcarecards23
@nyulangone
Such an amazing organization with amazing people
1
7
22
#SMART
Trial
#ACC24
the largest trial comparing the hemodynamic performance and clinical outcomes of SEV to BEV with more than 85% female representation
🫀SEV was superior to BEV for bioprosthetic valve dysfunction at 12 months for all definitions tested
@CardioNerds
#TAVR
0
8
22
Day 2
#SCAI2022
started the day discussing how we can decrease the infarct size in STEMI
@SCAI
@CardioNerds
@david_enze_wang
1
10
20
ORBITA-2: Exploring the Power of Placebo-Controlled PCI in stable angina
The original ORBITA trial turned heads with its findings. Now, ORBITA-2 steps up to assess the placebo-controlled efficacy of PCI on angina frequency.
#AHA23
@CardioNerds
1
12
21
Closing an inspiring conference journey
@miamivalves
Grateful for the journey so far and thrilled about what’s on the horizon in transcatheter therapies.
Big thanks to the incredible
@CardioNerds
team for making this experience unforgettable
@saahilaj
@a_h_ghoneem
@catweneboah
0
3
18
Changing the paradigm from DTB to DTU in management of AMI
#THT2023
🫀HF after AMI is common
🫀Deapote rapid revascularization, residual myocardial damage is seen in these patients
🫀Uncoupling the ventricle from vasculature can improve oxygen delivery and limit ischemic injury
1
6
20
The 3rd NYU Langone Critical Symposium kicks off with a great opening session and attendance of champions in the field. Time to nerd out
@CardioNerds
#critcarecards23
0
9
20
@PedroMDMSc
discussing the results of the TRISCEND Study using the Evoque TTVR, the first US FDA approved transcatheter therapy for tricuspid valve
@CardioNerds
@miamivalves
#TTVR
#Evoque
@saahilaj
@a_h_ghoneem
@catweneboah
LATE BREAKING NEWS.
#Evoque
#TTVR
@US_FDA
approved. Great day for pts with
#FixTR
#TreatTR
@EdwardsLifesci
@SusheelKodaliMD
@hahn_rt
@TCTMD
@KHERA_MD
@SachinGoelMD
@psorajja
@JoaoLCavalcante
@igeorge1975
@modine_thomas
@vonBardelebenRS
@LucySafi
2
33
119
0
6
19
In depth with ORBITA-2
#AHA23
@CardioNerds
❓Why eliminate antianginals?
❣️In ORBITA, patients were on high antianginal doses. However, real-world data doesn't reflect widespread use of 2-3 anti-anginals. Patients faced adherence and side effect challenges.
2
11
19
The best three-day conversation affecting the profession is happening May 19-22. Meet us in Atlanta for
#SCAI2022
@SCAI
@CardioNerds
@david_enze_wang
0
3
17
What you think you see in a coronary angiogram vs. the real deal with IVUS. Knowing what you’re dealing with makes all the difference
❣️Best practice: intracoronary imaging before and after PCI
#AHA23
@CardioNerds
0
7
18
Revascularization in multivessel disease
#SCAI2022
Check out: Implementing Guidelines Into Real-World Practice @ 2022 Scientific Sessions
@SCAI
@CardioNerds
@david_enze_wang
@AdnanKhalifMD
1
8
17
To wean or not to wean tMCS
❣️assess readiness to wean everyday
❣️keep in mind potential complications
❣️initial illness severity matters!
❣️don’t forget the value of echo
- LVOT VTI
-lateral e’ during ECMO weaning
❣️create your algorithm with clinical, hemodynamic and lab data
1
9
16
What an amazing case presented by
@Gurleen_Kaur96
so eloquently
@Cardiology
#CRITCARECARDS23
@nyulangone
@Gurleen_Kaur96
presenting a fascinating case of NICM-CS illustrating complex MCS decisions leading to successful heart transplant.
#CRITCARECARDS23
@EBohula
5
6
54
1
3
17
#DAPAMI
#AHA23
Evaluating the effect of dapagliflozin on cardiometabolic outcomes in acute MI without DM or chronic HF
🫀significant benefit in cardiometabolic outcomes
@CardioNerds
1
7
17
Acute MI CS at 2023 Western Pennsylvania Cardiogenic Shock Initiative Symposium
Highlights from the amazing discussions:
-risk atratification with SCAI staging
-culprit vs multivessel revasc
-LV support prior to revasc may lead to better outcomes
#shocksaturday
@AHN_CVI
1
7
17
Can’t imagine
#critcarecards23
without an acute PE case from
@jameshorowitzmd
Risk stratification of acute PE with high-inintermdiate risk remains to be a big challenge in clinical oractoce. Check out the Conposite Shock Score
0
5
16
Excited to announce the publication of our latest research article! Research is tough during training, but the mentorship and teamwork made it possible. Grateful for the opportunity to be part of such an incredible group.
@skarim01
@MHMedRes
@AHN_CVI
@GSAMRA12
@SCAI_WIN
#ACCFIT
🚨New
#FreeRead
Article in
@JICE_EP
3-Year Incidence of Pacemaker Implantation in Pts with Atrial Fibrillation & Sinus Node Dysfunction Receiving Ablation vs. Antiarrhythmic Drugs
📖🧐
by
@nazliokumus
,
@EmilyZeitler
, Abdelmoniem Moustafa, Maximiliano
0
4
12
1
3
16
Challenges in CS from
@manreetkanwar
#ACC23
#WCCardio
1. Definining Shock Stages 2. Focus on AMI-CS now we are starting to realize that HF-CS is the leading cause of CS 3. Phenotyping CS: identifying hemodynamic vs hemodynamic shock 4.Transitioning from drips to devices
@AHN_CVI
1
4
16
Start planning with
#SCAI2022
app!
Can't wait for this session: Pulmonary Embolism Interventions: The Future Is now
What sessions are you most excited about?
@SCAI
@CardioNerds
@david_enze_wang
@AdnanKhalifMD
0
4
16
#THT23
is only 7 days away! Can’t wait to learn more about the latest technologies and treatments in heart failure and cardiogenic shock from the experts in their fields. Take a look at the schedule here:
Join the
@CardioNerds
Conference Scholars at
#THT23
to learn about cutting edge and innovative drug- & device-based treatments for heart failure!
Follow
@nazliokumus
&
@sonuabrahammd
to keep up!
1
26
45
1
4
16
No longer the forgotten valve! Great presentation about how our understanding of tricuspid valve has changed
@miamivalves
@CardioNerds
The valvular structure is more variable then we thought in the past
Patient with 4 leaflets may have more residual TR than those with 3 leaflets
1
6
15
Vasoactive Meds in CS
@JasonKatzMD
#critcarecards23
❣️little data to guide the choice of agent
❣️Caution with epinephrine given initial lactate rise
❣️Know your agents and their mevhanism of action well
❣️Try to leverage pathophysiology to guide pharmacology
@CardioNerds
1
6
14
Great start to day 2
#THT2023
by discussing the role of shunts in HF
Ideal shint candidate:
🫀normal to borderline elevated LAP at rest with significant increase during exercise
🫀normal RV/RA function
🫀elevated LAP that leads to dyspnea
1
7
15
Thrilled to share my article on
#ACCLegConf
! Humbled to be the voice of my patients and colleagues. Kudos to the
@ACCinTouch
Editorial Fellowship team
@ACCFIT
@Cardiology
#ACCWIC
@AHN_CVI
@SabrinaIslamMD
@neerav928
@PaChapterACC
@rosspetersonmd
@KhandelwalMD
If you missed out on
#ACCLegConf
this year or have never been, look no further!
@nazliokumus
eloquently narrates her experience and talks about the joys of advocacy! Next year’s conference is 9/29-10/1/24
#ACCFIT
@ACCinTouch
0
2
3
0
4
14
Big news from
#TCT2023
! Partner 3 and Evolut Low-Risk data for 5 and 4 years reveal promising outcomes in the low-risk population. 🩺📈 The real excitement? The 10-year follow-up will be the key test for valve durability and performance
#CardioTwitter
@crfheart
#TAVR
#SAVR
0
4
15
Future of TAVR from Dr. Eberhard Grube
@miamivalves
❣️Deep dive into the explosive growth in TAVR worldwide
🫀extended indications
🫀Accelarated innovation platforms
🫀lifetime management: planning the future
🫀valve remodeling technologies
1
6
13
1
1
12
Patient phenotyping and prognostication in cardiogenic shock: not all shock is created equal!
@manreetkanwar
#THT23
🫀phenotyping comes first to know what you treat
🫀CS phenotyping at admission predict the odds of reaching more severe SCAI STAGES
2
4
13
Amazing discussion
#THT23
Decongestion matters but is it sufficient?
New ways to approach HF therapy
🫀Combination of decongestion with rapid uptitration of multiple drugs
🫀Therapies targeting neurohormonal, inflammatory adrenergic activation at acute and chronoc phase
2
6
12
1
4
12
PV Loops: the gold standard approach
#THT2023
🫀Simultaneous measurement of RV pressure and volume
🫀Can be used in assessment of RV contractility, afterload, response to preload reduction as well as RV diastolic function
🫀Helpful to predict long term clinical outcomes
1
9
13
The power of women inspiring women cannot be underestimated
@WomenAs1
@Womenintxp_mcs
#THT2023
🙏🏽❤️
@MariellJessup
9
12
127
0
3
13
@CardioNerds
gearing up for
#AHA23
. Get ready to catch insights from the key trial investigators behind LBCT’s and hot topics.
I have so many questions about the MINT and ORBITA-2 trials. What LBCT’s are you most excited about?
🎙️🌟Stay tuned for
#AHA23
interviews with
@CardioNerds
conference scholars and key trial investigators 🔜
@NaimaMaqsood9
@a_h_ghoneem
@nazliokumus
@sukritibanthiya
@MaryamBMD
@HanadBashirMD
@RamyDossMD
@InchausteguiC
Supported by an educational grant from Novo Nordisk Inc.
0
11
14
0
4
13
Honored, humbled, and incredibly excited to share my insightful interview with Dr
@rallamee
and Dr
@rajkumar_chris
!
@CardioNerds
#AHA23
@radcliffeCARDIO
Dive into our discussion on ORBITA-2.
@AHN_CVI
@AdnanKhalifMD
@KhandelwalMD
@ramzik1971
@MNestasie
@fouadjabbourMD
2
5
12
Phenomenal line of interviews
@CardioNerds
in collaboration with SCAI SHOCK
@SCAI
#Cardiotwitter
#MedTwitter
Thank you
@AmitGoyalMD
@Dr_DanMD
@AKansalMD
@agtruesdell
@ICUDocAP
@BenediktSchrage
2⃣
@nazliokumus
&
@AKansalMD
interview
@BenediktSchrage
& Dr. Alastair Proudfoot about the American vs European Cardiogenic Shock experience & need for ⬆️registry/trial data.
🔗
🧵(cont.)...
1
5
13
0
4
13
Such an honor to be a part of the abstract selection committee and work with such amazing mentors
Thank you for all the excellent abstracts from all over the world!
#CRITCARECARDS23
@CardioNerds
@ShashankSinhaMD
@ErinBohula
@jameshorowitzmd
@carlosalviar
@AmitGoyalMD
Star CardioNerds team presenting at the Awards poster session for the NYU Critical Care Symposium 💫💫
#critcarecards23
@CardioNerds
0
4
14
2
3
13
0
2
12
Honored to present a complex case
#THT2023
Thank you for the amazing questions and comments! Always a pleasure to discuss the ways of improving cardiogenic shock care and to learn from the experts
@manreetkanwar
@NavinKapur4
@NirUrielMD
@ranga1949
@AHN_CVI
@CardioNerds
#ACCFIT
Great case presented by
@nazliokumus
@CardioNerds
on a patient with CS after an Inferior MI
#THT2023
@manreetkanwar
@NavinKapur4
@NirUrielMD
0
2
16
0
4
12
Role of balloon valvuloplasty in MAC MS Excellent case presentation
@miamivalves
@CardioNerds
-MAC MS with mean gradient of 14 mmHG
-significant improvement in hemodynamics and functional capacity with Balloon Valvuloplasty
-patient comes back with worsening symptoms…
1
3
12
TAVI for AR
#TCT2023
ALIGN AR trial of
@JenaValve
meets prespecified efficacy and safety criteria! 🫀Significantly improved LV remodeling on echocardiography and enhanced heart failure functional status observed over one year for patients. 🌟
@crfheart
@TCTMD
#CardioTwitter
1
3
12
What are we learning?
🫀unloading LV with Impella stabilizes hemodynamics
🫀reduce ischemia
🫀protect from reperfusion injury
More to come with STEMI- DTU Pivotal trial!
@CardioNerds
@NavinKapur4
@sonuabrahammd
0
2
11
Exciting start at
@miamivalves
! Discussed remarkable progress in TAVR, with increasing ratios in patients under 65 and low risk patients
@CardioNerds
@saahilaj
@a_h_ghoneem
@catweneboah
1
6
12
Research in Critical Care Cardiology: What is the next frontier?
#critcarecards23
Excellent key note address from David Morrow
@nyulangone
2
6
12
0
4
12
🫀ShortCut Pivotal Study enrollment is complete
🫀We are expecting the results soon
🫀The device received breakthrough technology designation by the FDA in 2/2024
@CardioNerds
@a_h_ghoneem
@catweneboah
@saahilaj
0
5
10
What an amazing line of speakers. Thank you all our amazing speakers helping us make this session amazing addressing the importance of virtual domain in training, building a community and advocatting for the underserved populations
#CRITCARECARDS23
@nyulangone
@AHN_CVI
Join
@CardioNerds
to learn how to leverage the virtual domain for education in CCC
#CRITCARECARDS23
@JennaSkowronski
@nazliokumus
1
10
26
0
2
11
Clinical trials every CICU physician should know from
@AnnGageMD
Most of us assume that tube feeds must be held prior to extubation. I’m guilty of that too! Here is an excellent study questioning this approach:
Does this change your practice?
#critcarecards23
@CardioNerds
0
5
11
Peri-TAVR CAD management: to revascularize or not to revascularize
#SCAI2022
@SCAI
@CardioNerds
@david_enze_wang
0
4
10
Poster award sessions at 9:10
#critcarecards23
with
@CardioNerds
collaboration. Don’t miss the amazing poster presentations in QI, Research, Clinical Case and SIM categories.
@nyulangone
@jameshorowitzmd
@carlosalviar
@AnnGageMD
@JennaSkowronski
@AmitGoyalMD
@Gurleen_Kaur96
Poster boards lined up and ready for day
#2
of
#critcarecards23
. Many thanks to
@CardioNerds
for collaborating on the Poster Session!
0
4
15
0
5
11
Implementing an
#InterventionalCardiology
fellowship Match benefits both programs and fellows. Join me in supporting the
#SCAIFellowshipMatch
for 2025 ➡️
@SCAI
@CardioNerds
@AdnanKhalifMD
@SrikanthRadhak4
#ACCWIC
#ACCFIT
#CardioTwitter
#MedTwitter
0
1
10
#THT23
kicks off with an amazing opening session!
- An interactive forum for stake holders involved in the care HF patients
- Latest innovations
- Challenge conventional wisdom, inspire collaborations and drive new innovation
2
3
11
Feeling incredibly lucky and humbled to be part of an amazing team! Learning so much from each member, and enjoying their company. Can’t wait to reunite! Big thanks to
@AmitGoyalMD
and
@Dr_DanMD
for creating an invaluable learning space for trainees worldwide.
@CardioNerds
#AHA23
So proud of this amazing team of bright, committed, and FUN
@CardioNerds
❤️🤓
Thanks to
@nazliokumus
&
@NaimaMaqsood9
for leading the
@CardioNerds
Conference Scholars at
#AHA23
🤩
1
17
84
0
6
11
What is your approach? Distal radial access: Niche or routine?
#SCAI2022
#RadialFirst
@CardioNerds
@david_enze_wang
@SCAI
0
4
9
Discussing the revascularization guidelines with the experts
0
4
9
Thrilled to be a FIT expert at tonight’s journal club on the ORBITA-2 trial! Join us for a stimulating discussion with experts in the field.
#ORBITA2
#CardsJC
@CardioNerds
0
3
10
@malvarez_md
@AdnanKhalifMD
@SVRaoMD
@HenrytTimothy
@mjlimmd
@AbdullahAlabcha
@Pooh_Velagapudi
@sahilparikhmd
@ajaykirtane
@DougDrachmanMD
@HollandTamis
@FrederickWelt
@NinoNJ
@mickeylev1
We need 75% of Interventional PDs on board with the Match- tell your PD you want this!
@SCAI
1
5
15
0
2
9
❣️Valvular shock with Severe AI managed with LAVA ECMO
❣️significant improvement in hemodynamics following the insertion of LAVA ECMO shown in a case series
@CardioNerds
2
4
7
ORBITA-2 in context: PCI relieves angina in symptomatic patients with chronic CAD and is safe
It can he used as an alternative monotherapy to antianginal medications in patients that are unable to or unwilling to take antianginals
#AHA23
@CardioNerds
1
3
9
❣️Valve in Valve for the lifetime management of AS
🫀the number of TAVR in SAVR is increasing
🫀Planning ahead is crucial: think about the second valve while implanting the first one
🫀 more to learn about leaflet modification procedures
1
4
9
Great read about bioprosthetic aortic valve hemodynamics
#cardiotwitter
@JACCJournals
Bioprosthetic Aortic Valve Hemodynamics: Definitions, Outcomes, and Evidence Gaps: JACC State-of-the-Art Review | Journal of the American College of Cardiology
0
1
8
New valves in the treatment of AI from Dr Santiago Garcia
@miamivalves
@CardioNerds
Why do we need a different design for AI❓
🫀less calcification
🫀higher risk of valve embolization
🫀We’re expecting approval of Jenna Valve in US for AI soon
🫀Encouraging results with J-Valve
2
5
9
Valvular shock with severe AS
🫀Impella as the tMCS of choice 🫀Consider BAV with Impella in place for critical AS
🫀significant improvement in transvalvular gradients shown
@CardioNerds
1
4
9
Can’t wait to hear more about SCAI Featured Clinical Research abstracts
#SCAI2022
TOMORROW at 8:15 am -
@SVRaoMD
,
@AlexandraLansky
@GreggWStone
@HollandTamis
@DanielKolansky
& Subhash Banerjee discuss SCAI Featured Clinical Research abstracts published in JSCAI in the Centennial I, Ballroom Level – LL1
#SCAI2022
#ISupportJSCAI
#LateBreaking
0
3
10
0
2
9
@GreggWStone
addressed the ongoing RCT’s in Cardiogenic Shock and Impella
#THT2023
An exciting era in the use of Impella is coming up with the following trials:
🫀DanGer Shock
🫀RECOVER IV Trial
@CardioNerds
@sonuabrahammd
1
4
7
Great way to work on your Hands-on Skills that you need at Cardiac ICU
#ACC23
Stop by at the Simulation Center until Monday
@CardioNerds
@carlosalviar
@DrAlaaDiab
@AKansalMD
@UsmanA_24
@JennaSkowronski
@poojaprasad91
@catweneboah
@saahilaj
@AG_Kalluri
@jae_patton
1
6
9
Can’t wait to work with you Cali! Congrats👏🏻
Don’t let anyone tell you what you can or cannot do. With the help of your community, you can do anything.
I’m going to be a cardiologist 🫀🥹.
34
24
849
1
0
9
So proud to be a part of this amazing organization. All these inspiring physicians are here to advocate for our colleagues and patients, to improve the health care
#ACCLegConf
#HeartPAC
@ACCinTouch
#ACCWIC
#ACCFIT
@AHN_CVI
@KhandelwalMD
@PaChapterACC
0
0
9
Exciting discussion about management of anterior wall AMI
#SCAI2022
Is unloading the LV key to prevent Heart Failure?
@SCAI
@CardioNerds
@AdnanKhalifMD
@david_enze_wang
@MahabirSunita
0
2
8
Such an amazing organization
#CRITCARECARDS23
thanks to
@AniaCoats
such a pleasure to work with you
@nyulangone
1
3
8